Registration of catheter-related complications in adverse events reporting systems: a major underestimation of the real complication practice.
Bart J LaanMieke H GodfriedSuzanne E GeerlingsPublished in: Journal of infection prevention (2021)
Reporting and learning from preventable adverse events is crucial to improve patient safety. Although physicians should file and analyse adverse events by law in The Netherlands, it is unknown if these reporting systems are sufficiently used in clinical practice. This study is a substudy of the multicenter RICAT trial, a successful quality improvement project to reduce inappropriate use of intravenous and urinary catheters in medical wards in seven hospitals, in which we screened 5696 patients and documented 803 catheter-related complications. We also checked the adverse events reporting systems of these patients and found that only 13 (1.6%) of 803 catheter-related complications were registered. Of the infectious complications only five (10.9%) of 46 catheter-associated bloodstream infections and urinary tract infections were registered. We conclude that the reported complications were a major underestimation of the real complication practice in medical wards in The Netherlands. The RICAT trial is registered at Netherlands Trial Register, trial NL5438.
Keyphrases
- quality improvement
- patient safety
- healthcare
- end stage renal disease
- study protocol
- primary care
- adverse drug
- clinical trial
- phase iii
- newly diagnosed
- risk factors
- ejection fraction
- phase ii
- clinical practice
- chronic kidney disease
- randomized controlled trial
- prognostic factors
- urinary tract infection
- ultrasound guided
- peritoneal dialysis
- emergency department
- patient reported outcomes
- high dose